Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
JOHNSON & JOHNSON | JNJ | Nyse +17 Other | 7,377,149 | 154.6 USD | Stock | |
JOHNSON & JOHNSON | 000943981 | Berne S.E. | - | 140 CHF | ||
JOHNSON & JOHNSON | JNJ | Deutsche Boerse AG | 929 | 141.9 EUR | ||
JOHNSON & JOHNSON | JNJ * | Mexican S.E. | 1,197 | 2,560 MXN | ||
JOHNSON & JOHNSON | JNJ | Swiss Exchange | - | 136 USD | ||
JOHNSON & JOHNSON | JNJ | Frankfurt | 3,193 | 141.5 EUR | ||
JOHNSON & JOHNSON | JNJ | Wiener Boerse | 32 | 141.6 EUR | ||
JOHNSON & JOHNSON | 0R34 | London S.E. | 1,193 | 149.3 USD | ||
JOHNSON & JOHNSON | JNJ | Börse Stuttgart | 506 | 142.2 EUR | ||
JOHNSON & JOHNSON | JNJ | Bolsa De Valores De Colombia | 23 | 589,000 COP | ||
JOHNSON & JOHNSON | JNJ | Lima | - | 144.5 USD | ||
JOHNSON & JOHNSON | JNJ | Santiago S.E. | - | 148.3 USD | ||
JOHNSON & JOHNSON | JNJ | BOERSE MUENCHEN | 2,565 | 142.2 EUR | ||
JOHNSON & JOHNSON | 4JNJ | Borsa Italiana | - | 139.6 EUR | ||
JOHNSON & JOHNSON | JNJ | Bulgaria S.E. | 6 | 138.7 EUR | ||
JOHNSON & JOHNSON | JNJCL | Santiago S.E. | - | 155,930 CLP | ||
JOHNSON & JOHNSON | JNJ_KZ | Kazakhstan S.E. | 12 | 153.6 USD | ||
JOHNSON & JOHNSON | JNJ | Swiss Exchange | - | 500 CHF | ||
JOHNSON & JOHNSON | JNJ | Buenos Aires S.E. +1 Other | 10,565 | 11,386 ARS | Stock | |
JOHNSON & JOHNSON | JNJD | Buenos Aires S.E. | 569 | 10.9 USD | ||
JOHNSON & JOHNSON | JNJB34 | Sao Paulo | 6,606 | 52.45 BRL | Stock | |
JOHNSON & JOHNSON | JNJ0 | Deutsche Boerse AG +1 Other | - | 13.5 EUR | Stock | |
JOHNSON & JOHNSON | JNJ | NEO Exchange | 9,822 | 20.71 CAD | ||
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY | W1LT34 | Sao Paulo | 0 | 335 BRL | Stock | |
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY | WTW | Nasdaq +5 Other | 399,815 | 257.4 USD | Stock | |
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY | WTY | Deutsche Boerse AG | - | 234 EUR | ||
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY | WTY | Börse Stuttgart | - | 236 EUR | ||
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY | 0Y4Q | London S.E. | 3 | 250.8 USD | ||
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY | WTY | BOERSE MUENCHEN | - | 236 EUR | ||
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY | WTW N | Mexican S.E. | 0 | 4,025 MXN | ||
JOHNSON CONTROLS INTERNATIONAL PLC | JCI | Nyse +7 Other | 6,115,565 | 69.02 USD | Stock | |
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Deutsche Boerse AG | 112 | 62.55 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | JCI1 N | Mexican S.E. | 0 | 1,120 MXN | ||
JOHNSON CONTROLS INTERNATIONAL PLC | 0Y7S | London S.E. | 16 | 67.13 USD | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Börse Stuttgart | - | 63.43 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | BOERSE MUENCHEN | 110 | 63.32 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Frankfurt | 22 | 53.62 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Berne S.E. | - | - CHF | ||
WILLIS LEASE FINANCE CORPORATION | WLFC | Nasdaq +1 Other | 18,449 | 65.86 USD | Stock | |
WILLIS LEASE FINANCE CORPORATION | WIJ | Deutsche Boerse AG | - | 59 EUR | ||
JOHNSON OUTDOORS INC. | JOUT | Nasdaq | 74,352 | 36.94 USD | Stock | |
PRISM JOHNSON LIMITED | PRSMJOHNSN | Bombay S.E. +1 Other | 33,134 | 146 INR | Stock | |
PRISM JOHNSON LIMITED | PRSMJOHNSN | NSE India S.E. | 515,029 | 146.2 INR |
News (937)
Companies (58)
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-ca ...
Axfood AB is a Sweden-based company engaged in the food retail and wholesale trade in Sweden. The Companyâs retail business is conducted through three wholly owned chains: Willys, specializing in discount food retail; Hemkop, which is engaged in the sal ...
Allegion plc specializes in manufacturing and marketing security systems. Products are sold under the Cisa, Interflex, LCN, Schlage, Von Duprin, Aptiq, Bocom, Briton, Bricard, Dexter, Falcon, Glynn-Johnson, Ito Kilit, Ives, Kryptonite, Legge, Normbau, Ste ...
Willis Towers Watson Public Limited Company is a world leader in consulting, insurance brokerage and risk management software development. Revenues break down by activity as follows: - human capital and social benefits consulting services (35.6%): consul ...
Willis Towers Watson Public Limited Company is a world leader in consulting, insurance brokerage and risk management software development. Revenues break down by activity as follows: - human capital and social benefits consulting services (35.6%): consul ...
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: ...
Insiders
Mr. Willis A.
Johnson is a Chief Executive Officer at Willis Johnson & Associates, Inc. He provides a full complement of financial services to individuals as they go through the transitions in their corporate life.
Most corporate professionals will retire once in their life, but Mr. Johnson has assisted hundreds of clients to navigate through the retirement process over the course of his career.
During his over 35 years as an advisor, 13 years with a national financial advisory firm and 22 years as a principal at his own firm, Mr. Johnson implemented exclusive estate and financial planning techniques.
His structured methodology-- customized for each client-- is still the basis of his approach today.
He received a Bachelor of Business Administration in accounting from the University of Houston.
Willis J. Johnson is an entrepreneur who founded Copart, Inc., U-PULL-IT, Inc. and Takl, Inc. Presently, Mr. Johnson is Executive Chairman at Copart, Inc. Mr. Johnson is also on the board of Chorespros, Inc. and Takl, Inc. In his past career Mr. Johnson occupied the position of Director at U-PULL-IT, Inc.
Rodney Willis worked as a Principal at Avon Products, Bayer Corp., and Agfa Corp.
He then served as Head-Human Resources & Senior Vice President at Textron Corp., Inc. and Vice President-Human Resources at Thales USA, Inc. Willis holds an MBA from Long Island University, an undergraduate degree from Norfolk State University, and a graduate degree from Rider University.
Kristy Willis is currently the President at PeopleReady, Inc. She previously worked as the Director at Muscular Dystrophy Association, Inc., Catering Manager at Fillmore LC Holdings I LLC, and Senior Vice President-Western Division at Adecco USA, Inc. She completed her undergraduate degree at National University.
No results for this search
- Stock Market
- Advanced search
- Willis Johnson